Literature DB >> 32810894

Acute Hepatitis Is a Prominent Presentation of the Multisystem Inflammatory Syndrome in Children: A Single-Center Report.

Amanda Cantor1, Jonathan Miller1, Philip Zachariah2, Bernardo DaSilva3, Kara Margolis1, Mercedes Martinez1.   

Abstract

BACKGROUND AND AIMS: A newly recognized multisystem inflammatory syndrome in children (MIS-C) has had a paradigm-shifting effect on the perception of severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2) illness severity in children. We report the clinical and biochemical features of liver involvement, and the comorbidities that present with hepatitis, in a substantial cohort of patients. APPROACH AND
RESULTS: This is a retrospective cohort study of 44 patients with MIS-C admitted at Morgan Stanley Children's Hospital of New York-Presbyterian during April and May 2020. We evaluated the number of patients who developed hepatitis and examined both demographics and inflammatory laboratory values to ascertain those that were at higher risk for liver involvement and more severe disease. Hepatitis was present in 19 subjects (43%) and was associated with more severe disease. Persons with hepatitis had significantly higher rates of shock at presentation (21.1% vs. 0%; P = 0.008), greater respiratory support requirement (42.1% vs. 12%; P = 0.005), and longer hospitalization times (median, 7 [interquartile range {IQR}, 5, 10] vs. 4 days [IQR, 3.5, 6.5]; P < 0.05). Patients with hepatitis also had significantly higher levels of ferritin (706.9 vs. 334.2 mg/mL; P < 0.01), interleukin-6 (233.9 vs. 174.7 pg/mL; P < 0.05), troponin (83.0 vs. 28.5 ng/L; P < 0.05), and B-type natriuretic peptide (7,424.5 vs. 3,209.5 pg/mL; P < 0.05). The single patient with liver failure also developed multiorgan failure requiring vasopressors, hemodialysis, and mechanical ventilation. All patients were discharged, though >50% had persistent hepatitis up to 1 month after discharge.
CONCLUSIONS: Hepatitis is common in children with MIS-C and is associated with a more severe presentation and persistent elevation of liver function tests in many. Despite the positive outcomes reported here, close follow-up is warranted given the limited knowledge of the long-term impact of SARS-CoV-2 on the liver.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2020        PMID: 32810894      PMCID: PMC7655704          DOI: 10.1002/hep.31526

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  13 in total

1.  Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents in New York City.

Authors:  Eva W Cheung; Philip Zachariah; Mark Gorelik; Alexis Boneparth; Steven G Kernie; Jordan S Orange; Joshua D Milner
Journal:  JAMA       Date:  2020-07-21       Impact factor: 56.272

2.  COVID-19 and liver disease.

Authors:  Jian Sun; Alessio Aghemo; Alejandro Forner; Luca Valenti
Journal:  Liver Int       Date:  2020-06       Impact factor: 5.828

3.  New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase): Effects of age, sex, body mass index, and pubertal stage.

Authors:  Sarah Bussler; Mandy Vogel; Diana Pietzner; Kristian Harms; Theresa Buzek; Melanie Penke; Norman Händel; Antje Körner; Ulrich Baumann; Wieland Kiess; Gunter Flemming
Journal:  Hepatology       Date:  2018-05-16       Impact factor: 17.425

4.  COVID-19 Associated Hepatitis Complicating Recent Living Donor Liver Transplantation.

Authors:  Stephen M Lagana; Simona De Michele; Michael J Lee; Jean C Emond; Adam D Griesemer; Sheryl A Tulin-Silver; Elizabeth C Verna; Mercedes Martinez; Jay H Lefkowitch
Journal:  Arch Pathol Lab Med       Date:  2020-04-17       Impact factor: 5.534

5.  Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.

Authors:  Philip Zachariah; Candace L Johnson; Katia C Halabi; Danielle Ahn; Anita I Sen; Avital Fischer; Sumeet L Banker; Mirna Giordano; Christina S Manice; Rebekah Diamond; Taylor B Sewell; Adam J Schweickert; John R Babineau; R Colin Carter; Daniel B Fenster; Jordan S Orange; Teresa A McCann; Steven G Kernie; Lisa Saiman
Journal:  JAMA Pediatr       Date:  2020-10-05       Impact factor: 16.193

6.  Effect of hepatic steatosis on the progression of chronic hepatitis B: A prospective cohort and in vitro study.

Authors:  Yangqin Chen; Chunlei Fan; Yuhan Chen; Hui Liu; Shanshan Wang; Peiling Dong; Lei Li; Huiguo Ding
Journal:  Oncotarget       Date:  2017-04-24

7.  Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients.

Authors:  Jing Liu; Sumeng Li; Jia Liu; Boyun Liang; Xiaobei Wang; Hua Wang; Wei Li; Qiaoxia Tong; Jianhua Yi; Lei Zhao; Lijuan Xiong; Chunxia Guo; Jin Tian; Jinzhuo Luo; Jinghong Yao; Ran Pang; Hui Shen; Cheng Peng; Ting Liu; Qian Zhang; Jun Wu; Ling Xu; Sihong Lu; Baoju Wang; Zhihong Weng; Chunrong Han; Huabing Zhu; Ruxia Zhou; Helong Zhou; Xiliu Chen; Pian Ye; Bin Zhu; Lu Wang; Wenqing Zhou; Shengsong He; Yongwen He; Shenghua Jie; Ping Wei; Jianao Zhang; Yinping Lu; Weixian Wang; Li Zhang; Ling Li; Fengqin Zhou; Jun Wang; Ulf Dittmer; Mengji Lu; Yu Hu; Dongliang Yang; Xin Zheng
Journal:  EBioMedicine       Date:  2020-04-18       Impact factor: 8.143

8.  An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study.

Authors:  Lucio Verdoni; Angelo Mazza; Annalisa Gervasoni; Laura Martelli; Maurizio Ruggeri; Matteo Ciuffreda; Ezio Bonanomi; Lorenzo D'Antiga
Journal:  Lancet       Date:  2020-05-13       Impact factor: 79.321

Review 9.  Liver injury during highly pathogenic human coronavirus infections.

Authors:  Ling Xu; Jia Liu; Mengji Lu; Dongliang Yang; Xin Zheng
Journal:  Liver Int       Date:  2020-03-30       Impact factor: 8.754

10.  Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults.

Authors:  Jonas F Ludvigsson
Journal:  Acta Paediatr       Date:  2020-04-14       Impact factor: 4.056

View more
  16 in total

1.  Sudden onset hepatitis in children.

Authors:  Deirdre A Kelly; Zania Stamataki
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09       Impact factor: 73.082

2.  Clinical features and outcome of MIS-C patients: an experience from Central Anatolia.

Authors:  Gulsum Alkan; Ahmet Sert; Sadiye Kubra Tuter Oz; Melike Emiroglu; Resul Yılmaz
Journal:  Clin Rheumatol       Date:  2021-05-06       Impact factor: 2.980

3.  Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study.

Authors:  Mohit Kehar; Noelle H Ebel; Vicky L Ng; Jairo Eduardo Rivera Baquero; Daniel H Leung; Voytek Slowik; Nadia Ovchinsky; Amit A Shah; Ronen Arnon; Tamir Miloh; Nitika Gupta; Saeed Mohammad; Debora Kogan-Liberman; James E Squires; Maria Camila Sanchez; Amber Hildreth; Linda Book; Christopher Chu; Leina Alrabadi; Ruba Azzam; Bhavika Chepuri; Scott Elisofon; Rachel Falik; Lisa Gallagher; Howard Kader; Douglas Mogul; Quais Mujawar; Shweta S Namjoshi; Pamela L Valentino; Bernadette Vitola; Nadia Waheed; Ming-Hua Zheng; Steven Lobritto; Mercedes Martinez
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-06-01       Impact factor: 2.839

4.  Liver involvement in children with SARS-COV-2 infection: Two distinct clinical phenotypes caused by the same virus.

Authors:  Adriana Perez; Amanda Cantor; Bryan Rudolph; Jonathan Miller; Debora Kogan-Liberman; Qi Gao; Bernardo Da Silva; Kara G Margolis; Nadia Ovchinsky; Mercedes Martinez
Journal:  Liver Int       Date:  2021-04-22       Impact factor: 8.754

Review 5.  Multifactorial Rare Diseases: Can Uncertainty Analysis Bring Added Value to the Search for Risk Factors and Etiopathogenesis?

Authors:  Domenica Taruscio; Alberto Mantovani
Journal:  Medicina (Kaunas)       Date:  2021-01-28       Impact factor: 2.430

6.  The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature.

Authors:  Lucia Novelli; Francesca Motta; Maria De Santis; Aftab A Ansari; M Eric Gershwin; Carlo Selmi
Journal:  J Autoimmun       Date:  2020-12-14       Impact factor: 7.094

7.  Impact of COVID-19 Pandemic on Pediatrics and Pediatric Transplantation Programs.

Authors:  Steven Lobritto; Lara Danziger-Isakov; Marian G Michaels; George V Mazariegos
Journal:  Front Pediatr       Date:  2020-12-10       Impact factor: 3.418

8.  New Onset of Hepatic Steatosis Post-Severe Multisystem Inflammatory Syndrome in Children (MIS-C): A Case Report.

Authors:  Rossella Sica; Serena Pennoni; Laura Penta; Giuseppe Di Cara; Alberto Verrotti
Journal:  Int J Environ Res Public Health       Date:  2021-06-29       Impact factor: 3.390

Review 9.  Gastrointestinal, hepatic and pancreatic manifestations of COVID-19 in children.

Authors:  Francesco Pegoraro; Sandra Trapani; Giuseppe Indolfi
Journal:  Clin Res Hepatol Gastroenterol       Date:  2021-10-02       Impact factor: 3.189

Review 10.  Coronavirus Disease 2019-Related Multisystem Inflammatory Syndrome in Children: A Systematic Review and Meta-Analysis.

Authors:  Ji-Gan Wang; Zhi-Juan Zhong; Meng Li; Jun Fu; Yu-Heng Su; You-Min Ping; Zi-Ji Xu; Hao Li; Yan-Hao Chen; Yu-Li Huang
Journal:  Biochem Res Int       Date:  2021-07-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.